Sentences with phrase «current uncertain times»

Lorillard presents a good buying opportunity in current uncertain times for investors seeking yield, strong cash flow generation and consistent earnings.

Given the current uncertain times we live in, the bars to returning to the US need to be addressed.

Not exact matches

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

My aim was to get a statistically relevant idea as to how companies are managing themselves during these uncertain times, and the effects the current conditions have had on them.

Hard to know whether that will help: over the five years under its current management, the fund has been a lot more volatile (bigger maximum drawdown but much faster recovery) and more profitable than its peers; the question is whether, in uncertain times, investors will buy that combo — even after the generous cost reduction.

My investment horizon is medium to long term (> 5 years) with 11 - 12 % expected returns, but uncertain about entering the markets at the current «all time high» levels.

«As we celebrate our 30th anniversary it's the right time launch a mid-year conference and use all our expertise and experience to further help the travel industry thrive during these current uncertain economic times.»

The images presented form a record of modern times, and between each work a new dialogue emerges — one that questions and provokes the current state of play, but remains uncertain, revealing something dark, disquieting and not yet fully formed.

Models all produce natural variability, many of which show temperature flatlines over decadal timescales, and given the wide importance of natural variability over < 10 year time scales and uncertain forcings, one can absolutely not claim that this is inconsistent with current thinking about climate.

«While we understand it can be scary to travel during this uncertain time, travel insurance coverage for pregnancy remains the same, regardless of current events.»

The headlines call the current real estate climate turbulent and uncertain, but Patricia G. Will, CEO of assisted living owner and operator Belmont Corp., calls it a good time to be a seniors housing developer.

In these uncertain times, many home owners have had to face the fact that the current market value of their homes is less than they once thought.